Introduction
An early event in the process of atherogenesis (1) is considered to be oxidative stress including accumulation of oxidized LDL (oxLDL) and dysfunction of the vascular endothelium.
Lipid components of oxLDL such as linoleyl hydroperoxide and lysophosphatidyl-choline, augment the ability of vascular endothelial cells to express cytokine-mediated vascular cell adhesion molecule-1 (VCAM-1) (2). Oxysterols are also major components of oxLDL and known to have various biological activities (3). Expression of the adhesion molecules, VCAM-1 and intercellular adhesion molecule-1 (ICAM-1) (1), on vascular endothelial cells are known to play an important role in atherosclerosis in diabetes mellitus. Accelerated atherosclerosis is the most important complication of diabetes mellitus. In particular, Otsuka et al. (4) have found an increased plasma levels of soluble VCAM-1 (sVCAM-1) in patients with type 2 diabetes mellitus and suggested the importance of endothelial dysfunction. In addition, plasma cell adhesion molecules have been reported to be implicated in the development and progression of the diabetic retinopathy (5) and of peripheral neuropathy in diabetes mellitus (6). Diabetic nephropathy was shown to be associated with the sVCAM-1 concentration by multivariate regression analysis (7). However, the biological significance of soluble forms of these adhesion molecules is not fully understood.
We compared in this study, the sVCAM-1 levels in the patients with diabetic nephropathy in concerning with plasma 7-ketocholesterol levels, which is major cholesterol auto-oxidation products.
Methods
We studied 31 patients with type 2 diabetes mellitus (63.9+11.3 years old) and age-matched healthy controls (60.0+12.3 y.o.). The patients were divided into three subgroups according to the degree of diabetic nephropathy as follows : 15 cases of the normoalbuminuria (urinary albumin (U.Alb) <30 mg/gCr), microalbuminuria (30<U.Alb<300 mg/gCr) and macroalbuminuria (U.Alb> 300 mg/gCr). The patient characterization were summarized in Table 1 . There were no difference in the age and sex ratio, HbA1c and the kinds of treatment among the subgroups, except serum creatinine which was higher in macroalbuminuria than that in normoalbuminuria. All of the patients with micro-and macro-albuminuria were administered with angiotensin-converting-enzyme (ACE) inhibitor as a renoprotective agent (8).
Fasting blood samples were obtained using EDTA-2Na as an anticoagulant.
Plasma levels of VCAM-1 were determined using specific ELISA kits (Biosource International, CA, USA). Plasma 7-ketocholesterol was measured by gas-chromatography/mass-spectrometry as described previously (9).
Statistical analysis was performed using analysis of variance and the least significant difference to compare ence was not detected among the subgroups. Soluble VCAM-1 showed weak correlation with 7-ketocholesterol (r=0.42, p=0.024), TC (r=0.42, p=0.014) and LDL-C (r =0.38, p =0.044).
However no correlation was demonstrated between sVCAM-1 and HbA1c nor creatinine levels.
Discussion
The interactions between blood cells and the vascular wall has been regarded as an important triggering process in atherogenesis.
Cell adhesion molecules play an important role for this interaction and VCAM-1 is one of the major molecules (10). The expression of VCAM-1 has been known to be enhanced in atherosclerotic lesions (11). The levels of sVCAM-1 in plasma may reflect its expression in endothelial cells and increased plasma VCAM-1 is regarded as an indicator of endothelial damage (4).
Oxidative stress is also concerning with endothelial injury especially in diabetes mellitus (12). Oxidatively modified LDL has been implicated as an important oxidative signal in the pathogenesis of atherosclerosis. Products of lipid oxidation such as fatty acid hydroperoxide or lysophosphatidylcholine (2) are already reported to enhance the expression and extracellular release of adhesion molecules (13, 14) . Oxysterols are also revealed to be the important lipid components in oxidized lipoproteins (3). In our previous study, we reported the increased levels of plasma oxysterols in diabetic patients 
